Advertisement

History of the Relationship Between Smoking and Bladder Cancer: A Public Health Perspective

      Cigarette smoking is the leading preventable cause of cancer worldwide and associated with substantial morbidity. Here, we chronicle how the relationship between smoking and the development of bladder cancer came to be understood. We describe the evidence that established the causal effect of smoking cigarettes on bladder cancer and highlight the scientists involved in these discoveries. Using Surgeon General's Reports, from the mid-1900’s to 2020, we provide a historical narrative of the discovery of the link between cigarette smoking and bladder cancer.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • From the Centers for Disease Control and Prevention
        Tobacco use–United States, 1900-1999.
        JAMA. 1999; 282 (PMID:10605963): 2202-2204
        • Nabavizadeh B
        • Amend GM
        • Breyer BN.
        Workers died of dyes: the discovery of occupational bladder cancers.
        Urology. 2021; 154 (Epub 2021 May 17. PMID:34010678): 4-7https://doi.org/10.1016/j.urology.2021.05.010
        • Freedman ND
        • Silverman DT
        • Hollenbeck AR
        • Schatzkin A
        • Abnet CC
        Association between smoking and risk of bladder cancer among men and women.
        JAMA. 2011; 306: 737-745
        • Proctor RN.
        Angel H Roffo: the forgotten father of experimental tobacco carcinogenesis.
        Bull World Health Organ. 2006; 84: 494-496https://doi.org/10.2471/blt.06.031682
        • Holsti LR
        • Ermala P.
        Papillary carcinoma of the bladder in mice, obtained after peroral administration of tobacco tar.
        Cancer. 1955; 8: 679-682https://doi.org/10.1002/1097-0142(1955)8:4<679::AID-CNCR2820080405>3.0.CO;2-W
        • Dipaolo Joseph A.
        • Moore George E.
        Effect on mice of oral painting of cigarette-smoke condensate.
        JNCI. 1959; 23: 529-534https://doi.org/10.1093/jnci/23.3.529
        • Levin ML
        • Lilienfeld AM
        • Moore GE.
        The association of smoking with cancer of the urinary bladder in humans.
        AMA Arch Intern Med. 1956; 98: 129-135https://doi.org/10.1001/archinte.1956.00250260001001
        • Okajima E
        • Hiramatsu T
        • Iriya K
        • Ijuin M
        • Matsushima S.
        Effects of sex hormones on development of urinary bladder tumours in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
        Urol Res. 1975; 3: 73-79
        • Bayne-Jones S.
        Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service.
        US Department of Health, Education, and Welfare, Public Health Service, 1964
        • Capella M.L.
        • Taylor C.R.
        • Webster C.
        The effect of cigarette advertising bans on consumption: a meta-analysis.
        J Advertising. 2008; 37: 7-18https://doi.org/10.2753/joa0091-3367370201
        • Radomski JL
        • Brill E.
        Bladder cancer induction by aromatic amines: role of N-hydroxy metabolites.
        Science. 1970; 167 (PMID:5411180): 992-993https://doi.org/10.1126/science.167.3920.992
        • Yamasaki E
        • Ames BN.
        Concentration of mutagens from urine by absorption with the nonpolar resin XAD-2: cigarette smokers have mutagenic urine.
        Proc Natl Acad Sci U S A. 1977; 74 (PMID:333441PMCID: PMC431630): 3555-3559https://doi.org/10.1073/pnas.74.8.3555
        • Bertram JS
        • Craig AW.
        Specific induction of bladder cancer in mice by butyl-(4-hydroxybutyl)-nitrosamine and the effects of hormonal modifications on the sex difference in response.
        Eur J Cancer. 1972; 8: 587-594
        • Shopland DR
        The Health Consequences of Smoking: Cancer: A Report of the Surgeon General.
        US Department of Health, Education, and Welfare, Public Health Service, 1982
        • Samet JM.
        The 1990 report of the surgeon general: the health benefits of smoking cessation.
        Am Rev Respir Dis. 1990; 142: 993-994https://doi.org/10.1164/ajrccm/142.5.993
        • Weir JM
        • Dunn JE.
        Smoking and mortality: a prospective study.
        Cancer. 1970; 25: 105-112
        • Welty CJ
        • Wright JL
        • Hotaling JM
        • et al.
        Persistence of urothelial carcinoma of the bladder risk among former smokers: results from a contemporary, prospective cohort study.
        Urol Oncol. 2014; 32: 25.e21-25.e25https://doi.org/10.1016/j.urolonc.2012.09.001
        • Jin F
        • Thaiparambil J
        • Donepudi SR
        • et al.
        Tobacco-specific carcinogens induce hypermethylation, DNA adducts, and DNA damage in bladder cancer.
        Cancer Prev Res (Phila Pa). 2017; 10: 588-597https://doi.org/10.1158/1940-6207.CAPR-17-0198
        • United States
        Public Health Service. Office of the Surgeon General, issuing body. | National Center for Chronic Disease Prevention and Health Promotion (U.S.). Office on Smoking and Health, issuing body. Smoking Cessation: A Report of the Surgeon General.
        A Report of the Surgeon General. 2020 (Published online)
        • Commissioner, O. of the
        FDA requires new health warnings for cigarette packages and advertisements.
        U.S. Food and Drug Administration, 2020 (Retrieved March 31, 2022, from)